T
Tenaya Therapeutics, Inc. (TNYA)
NMS – Real vaqt narxi. Valyuta: USD
1.00
+0.00 (0.19%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.99
-0.01 (-0.85%)
Bozordan keyin: May 12, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
1.00
+0.00 (0.19%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.99
-0.01 (-0.85%)
Bozordan keyin: May 12, 2026, 7:59 PM EDT
Tenaya Therapeutics, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, Qo'shma Shtatlarda yurak kasalliklarini davolash uchun terapiyalarni kashf etadi, ishlab chiqadi va yetkazib beradi. Uning asosiy mahsulot nomzodlari orasida TN-201, myosin bog'lovchi protein C3 bilan bog'liq gipertrofik kardiomiopatiya uchun gen terapiyasi, bu 1b/2 bosqichli klinik sinovda; TN-401, plakophilin 2 bilan bog'liq o'ng qorincha aritmiyali kardiomiopatiya uchun gen terapiyasi, bu 1b/2 bosqichli klinik sinovda; va TN-301, kichik molekulali gistondeatsetilaza-6, saqlangan ejeksiyon fraktsiyasi bilan yurak etishmovchiligi uchun, bu 1-bosqichli klinik sinovda. Kompaniya o'z mahsulotlarini gen qo'shish, genni tahrirlash, genni jim qilish va hujayralarni tiklash orqali ishlab chiqadi. U Alnylam Pharmaceuticals, Inc. bilan kardiyovaskulyar kasalliklarni davolash uchun yangi gen maqsadlarini aniqlash va tasdiqlash bo'yicha tadqiqot hamkorlik shartnomasiga ega. Tenaya Therapeutics, Inc. 2016 yilda ro'yxatga olingan va shtab-kvartirasi Janubiy San-Frantsisko, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Benoit G. Bruneau Ph.D. | Scientific Founder |
| Dr. Bruce R. Conklin M.D. | Scientific Founder |
| Dr. Deepak Srivastava M.D. | Scientific Founder, Chairman of Scientific Advisory Board & Director |
| Dr. Eric N. Olson Ph.D. | Scientific Founder & Member of Scientific Advisory Board |
| Dr. Kee-Hong Kim Ph.D. | Chief Technology Officer |
| Dr. Saptarsi Haldar M.D. | Scientific Founder |
| Dr. Sheng Ding Ph.D. | Scientific Founder |
| Dr. Whittemore G. Tingley M.D., PH.D. | Chief Medical Officer |
| Mr. Faraz Ali M.B.A. | CEO, Interim Principal Financial Officer & Director |
| Mr. Tomohiro Higa M.B.A. | Senior Vice President of Finance & Interim Principal Accounting Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-06 | 10-Q | tnya-20260331.htm |
| 2026-04-16 | DEFA14A | tnya-a14a-2025.htm |
| 2026-03-11 | 8-K | tnya-20260311.htm |
| 2026-03-05 | 8-K | tnya-20260304.htm |
| 2026-02-03 | S-8 | tnya-20260202.htm |
| 2026-01-30 | 8-K | tnya-20260126.htm |
| 2026-01-02 | 8-K | tnya-20251231.htm |
| 2025-12-12 | 8-K | d67398d8k.htm |
| 2025-12-11 | 8-K | d68368d8k.htm |
| 2025-11-10 | 8-K | tnya-20251110.htm |